MOH — authorised 31 July 2018
- Marketing authorisation holder: SHIONOGI INC
- Status: likely_approved
🇮🇱 Mulpleta in Israel
MOH authorised Mulpleta on 31 July 2018
Marketing authorisation
Mulpleta in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in Israel
Frequently asked questions
Is Mulpleta approved in Israel?
Yes. MOH authorised it on 31 July 2018.
Who is the marketing authorisation holder for Mulpleta in Israel?
SHIONOGI INC holds the Israeli marketing authorisation.